Brief: Symrise AG Says It Decides To Divest Its Terpenes Business And Makes Non-Cash Impairment

Symrise AG

12/01/2026 23:14

Jan 12 (Reuters) - Symrise AG SY1G.DE:

EQS-ADHOC: SYMRISE AG DECIDES TO DIVEST ITS TERPENES BUSINESS AND MAKES NON-CASH IMPAIRMENT.  SYMRISE AG'S INVESTMENT IN SWEDENCARE AB IS SUBJECT TO A NON-CASH IMPAIRMENT.

SYMRISE AG - RECORDS EUR 145 MILLION IMPAIRMENT CHARGE IN Q4 2025

SYMRISE AG - INVESTMENT IN SWEDENCARE AB FACES NON-CASH IMPAIRMENT

SYMRISE AG: NON-CASH IMPAIRMENT CHARGE OF APPROXIMATELY EUR 145 MILLION IS RECORDED IN Q4 OF 2025

SYMRISE AG: THIS HAS A NEGATIVE IMPACT ON EBITDA

Source text: ID:nEQ1yfyJ2a

Further company coverage: SY1G.DE

 ((Reuters.Briefs@thomsonreuters.com;))